Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion

The role of glucagon and GLP‐1 receptors in first and second phase insulin secretion[Image: see text]

Detalles Bibliográficos
Autores principales: Kimura, Tomohiko, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340864/
https://www.ncbi.nlm.nih.gov/pubmed/35543083
http://dx.doi.org/10.1111/jdi.13831
_version_ 1784760487971389440
author Kimura, Tomohiko
Kaku, Kohei
author_facet Kimura, Tomohiko
Kaku, Kohei
author_sort Kimura, Tomohiko
collection PubMed
description The role of glucagon and GLP‐1 receptors in first and second phase insulin secretion[Image: see text]
format Online
Article
Text
id pubmed-9340864
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93408642022-08-02 Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion Kimura, Tomohiko Kaku, Kohei J Diabetes Investig Commentary The role of glucagon and GLP‐1 receptors in first and second phase insulin secretion[Image: see text] John Wiley and Sons Inc. 2022-06-02 2022-08 /pmc/articles/PMC9340864/ /pubmed/35543083 http://dx.doi.org/10.1111/jdi.13831 Text en © 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Commentary
Kimura, Tomohiko
Kaku, Kohei
Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
title Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
title_full Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
title_fullStr Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
title_full_unstemmed Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
title_short Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
title_sort clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340864/
https://www.ncbi.nlm.nih.gov/pubmed/35543083
http://dx.doi.org/10.1111/jdi.13831
work_keys_str_mv AT kimuratomohiko clinicalrelevanceofdualagonistofglucagonandglucagonlikepeptide1receptorstoachievefunctionalrestorationoffirstandsecondphaseinsulinsecretion
AT kakukohei clinicalrelevanceofdualagonistofglucagonandglucagonlikepeptide1receptorstoachievefunctionalrestorationoffirstandsecondphaseinsulinsecretion

Ejemplares similares